17PHER2-positive breast cancer resistance to trastuzumab is...

17PHER2-positive breast cancer resistance to trastuzumab is associated with metabolic switch

Dubianski, R, Sarnowska, E, Leszczynski, M, Kubala, S, Olszewski, W, Rusetska, N, Jagiello-Gruszfeld, A I, Konopinski, R, Sarnowski, T J, Siedlecki, J A, Nowecki, Z I
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy268.016
Date:
October, 2018
File:
PDF, 80 KB
2018
Conversion to is in progress
Conversion to is failed